Effects of Recombinant Human Macrophage Colony-Stimulating Factor on Atherosclerotic Lesions Established in the Aorta of High Cholesterol-Fed Rabbits.
スポンサーリンク
概要
- 論文の詳細を見る
Anti-atherosclerotic effects of human macrophage colony-stimulating factor were investigated using rabbits fed a high cholesterol diet. Rabbits fed a diet containing 2% cholesterol for 59 days developed hyperlipidemia and atheromatous aortic plaques. They were then administered 80μg/kg/day of either macrophage colony-stimulating factor or human serum albumin, as a control, for the next 12 weeks. Compared with the control group, rabbits treated with macrophage colony-stimulating factor had significantly fewer plaques on the inner surface of the thoracic and abdominal aortae, and half the sectional area of thickened intima in the aortic arch, as well as in the thoracic and abdominal aortae. Macrophage colony-stimulating factor also decreased the cholesterol content of the atherosclerotic lesions. Serobiochemical analyses revealed that macrophage colony-stimulating factor increased the levels of high density lipoprotein-cholesterol significantly, without influencing other lipid parameters such as the level of low density lipoproteins. The effects of macrophage colony-stimulating factor were evident until the fourth week of drug injection, at which time anti-human macrophage colonystimulating factor antibodies were clearly induced in the serum. These results indicate that exogenously administered macrophage colony-stimulating factor suppresses atherosclerotic lesions induced by a high cholesterol diet by activating lipid metabolism in vivo.
- 社団法人 日本生化学会の論文
著者
-
Irie Hiroyuki
Pharmaceutical Research Division Welfide Corporation
-
Hanada Shuichi
Pharmaceutical Research Division Yoshitomi Pharmaceutical Industries
-
Koshiba Hiroshi
Pharmaceutical Research Division Welfide Corporation
-
Nakamura Norifumi
Pharmaceutical Research Division Welfide Corporation
-
Koyama Mamoru
Pharmaceutical Research Division Welfide Corporation
-
NAITO Kazuhide
Pharmaceutical Research Division, Welfide Corporation
-
Yada Kouji
Pharmaceutical Research Division Welfide Corporation
-
Asakura Eiji
Pharmaceutical Research Division Welfide Corporation
-
Abe Syun-ichi
Pharmaceutical Research Division Welfide Corporation
-
Hanamura Takuji
Pharmaceutical Research Division Welfide Corporation
-
Kimura Kazuyuki
Pharmaceutical Research Division Welfide Corporation
-
Shibata Hiroshi
Pharmaceutical Research Division Welfide Corporation
-
Yamauchi Takeshi
Pharmaceutical Research Division Welfide Corporation
-
Koshiba Hiroshi
Pharmaceutical Research Division, Welfide Corporation
関連論文
- PE-310 Protective Effects of Atorvastatin on the Injury-induced Coronary Vascular Remodeling in Pigs(Restenosis, basic/clinical-4 (IHD) PE52,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Therapeutic Potential of a Specific Chymase Inhibitor in Atopic Dermatitis
- Mechanism of coma induced by medium-chain triglycerides emulsion in animal
- Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils
- Effects of Recombinant Human Macrophage Colony-Stimulating Factor on Atherosclerotic Lesions Established in the Aorta of High Cholesterol-Fed Rabbits
- Detection of antigen-specific IgE by enzyme immunoassay (EIA).
- A Discussion on Reduced Cardiotoxicity of Adriamycin-Oxidized Dextran Conjugate (ADM-OXD)
- Changes of Myelotoxicity of Adriamycin by the Conjugation with the High Molecular Weight Compound
- Effects of Recombinant Human Macrophage Colony-Stimulating Factor on Atherosclerotic Lesions Established in the Aorta of High Cholesterol-Fed Rabbits.